3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
44
Triple Negative Breast Neoplasms
20
Breast Neoplasms
16
Carcinoma, Non-Small-Cell Lung
14
Neoplasm Metastasis
10
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Neoplasms
6
Adenocarcinoma
6
Cholangiocarcinoma
5
Stomach Neoplasms
4
Gallbladder Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Esophageal Neoplasms
4
Biliary Tract Neoplasms
4
Uterine Cervical Neoplasms
3
Recurrence
3
Pancreatic Adenocarcinoma
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Small Cell Lung Carcinoma
2
Sarcoma
2
Rectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Pancreatic Ductal
2
Carcinoma, Hepatocellular
2
Interventions
pembrolizumab
6
Injections
6
senaparib
4
toripalimab
3
tislelizumab
3
Bevacizumab
3
sintilimab
2
Technetium
2
Specimen Handling
2
Nivolumab
2
Ipilimumab
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Blood Specimen Collection
2
zimberelimab
1
tumor-cells apoptosis factor, human
1
tazemetostat
1
spartalizumab
1
sacituzumab govitecan
1
rucaparib
1
osimertinib
1
olaparib
1
etoposide phosphate
1
enzalutamide
1
envafolimab
1
cemiplimab
1
cedazuridine
1
atezolizumab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
Albumin-Bound Paclitaxel
×
1 year
×
Clear all
No trials found.